Amyloid beta 25-35 impairs reconsolidation of object recognition memory in rats and this effect is prevented by lithium carbonate

Neuroscience Letters

Volumn 548, Issue , 2013, Pages 79-83

  Álvarez Ruíz, Yarummy ^a   Carrillo Mora, Paul ^b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE REHABILITACIÓN   (Mexico)

Author keywords

Alzheimer's disease; Amyloid beta; Lithium carbonate; Memory reconsolidation; Object recognition memory

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; DIZOCILPINE; LITHIUM CARBONATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; MALE; MEMORY CONSOLIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECOGNITION;

ALZHEIMER'S DISEASE; AMYLOID BETA; LITHIUM CARBONATE; MEMORY RECONSOLIDATION; OBJECT RECOGNITION MEMORY;

AMYLOID BETA-PEPTIDES; ANIMALS; DRUG INTERACTIONS; FORM PERCEPTION; HIPPOCAMPUS; LITHIUM CARBONATE; MALE; MEMORY; PEPTIDE FRAGMENTS; RATS; RATS, WISTAR; RECOGNITION (PSYCHOLOGY); RECOVERY OF FUNCTION;

EID: 84880136003     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2013.06.003     Document Type: Article

References (40)

1. Alberini C.M. The role of reconsolidation and the dynamic process of long, term memory formation and storage. Front. Behav. Neurosci. 2011, 5:1-10.
2. Atwood C.S., Obrenovich M.E., Liu T., Chan H., Perry G., Smith S.A., Martins R.N. Amyloid-β: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res. Rev. 2003, 43:1-16.
3. Banchaabouchi M.A., Peña de Ortiz S., Menéndez R., Ren K., Maldonado-Vlaar C.S. Chronic lithium decreases Nurr1 expression in the rat brain and impairs spatial discrimination. Pharmacol. Biochem. Behav. 2004, 79:607-621.
4. Brown T.E., Lee B.R., Sorg The B.A. NMDA antagonist MK-801 disrupts reconsolidation of a cocaine-associated memory for conditioned place preference but not for self-administration in rats. Learn. Mem. 2008, 15:857-865.
5. Carrillo-Mora P., Pérez De la Cruz V., Fortoul van Der Goes T.I., Santamaría A. Protective effect of systemic l-kynurenine and probenecid administrations on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus. Behav. Brain Res. 2010, 210:240-250.
6. Clare L., Woods R.T. Cognitive training and cognitive rehabilitation for people with early-stage Alzheimer's disease: a review. Neuropsychol. Rehab. 2004, 14:385-401.
7. De Lima M.N., Laranja D.C., Bromberg E., Roesler R., Schroder N. Pre- or post-training administration of the NMDA receptor blocker MK-801 impairs object recognition memory in rats. Behav. Brain Res. 2005, 156:139-143.
8. Diergaarde L., Schoffelmeer A.N.M., De Vries T.J. Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories. Eur. J. Pharmacol. 2008, 585:453-457.
9. Eckman C.B., Eckman E.A. An update on the amyloid hypothesis. Neurol. Clin. 2007, 25:669-682.
10. Ennaceur A., Delacour J. A new one-trial test for neurobiological studies of memory in rats. 1: behavioral data. Behav. Brain Res. 1988, 31:47-59.
11. Freir D.B., Fedriani R., Scully D., Smith I., Selkoe D., Walsh D. Aβ oligomers inhibit synapse remodelling necessary for memory consolidation. Neurobiol. Aging 2011, 32:2211-2218.
12. Grandjean E.M., Aubry J.M. Lithium: updated human knowledge using an evidence-based approach. Part II: clinical pharmacology and therapeutic monitoring. CNS Drugs 2009, 23:331-349.
13. Haass C., Selkoe D. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat. Rev. Mol. Cell Biol. 2007, 8:101-112.
14. Holscher C., Gengler S., Gault V.A., Harriott P., Mallot H.A. Soluble beta-amyloid [25-35] reversibly impairs hippocampal synaptic plasticity and spatial learning. Eur. J. Pharmacol. 2007, 561:85-90.
15. Kaminsky Y.G., Marlatt M.W., Smith M.A., Kosenko E.A. Subcellular and metabolic examination of amyloid-β peptides in Alzheimer disease pathogenesis: evidence for Aβ 25-35. Exp. Neurol. 2010, 221:26-37.
16. Kimura T., Yahashita S., Nakao S., Park J.M., Murayama M., Mizoroki T. GSK-3β is required for memory reconsolidation in adult brain. PLoS ONE 2008, 3:e3540.
17. Larkin A.E., Fahey B., Gobbo O., Callaghan C.K., Cahill E., O'Mara S.M., Kelly A.M. Blockade of NMDA receptors pre-training, but not post-training, impairs object displacement learning in the rat. Brain Res. 2008, 1199:126-132.
18. Lee J.L.C., Everitt B.J. Appetitive memory reconsolidation depends upon NMDA receptor-mediated neurotransmission. Neurobiol. Learn. Mem. 2008, 90:147-154.
19. Lenox R.H., Hahn C.G. Overview of the mechanism of action of lithium in the brain: fifty-year update. J. Clin. Psychiatry 2000, 61:5-15.
20. Leroy K., Ando K., Heraud C., Yilmaz Z., Authelet M., Boeynaems J.M., Buée L., De Decker R., Brion J.P. Lithium treatment arrests the development of neurofibrillary tangles in mutant Tau transgenic mice with advanced neurofibrillary pathology. J. Alzheimers Dis. 2010, 19:705-719.
21. Millucci L., Raggiaschi R., Franceschini D., Terstappen G., Santucci A. Rapid aggregation and assembly in aqueous solution of Aβ (25-35) peptide. J Biosci. 2009, 34:293-303.
22. Nader K.K., Einarsson E.O. Memory reconsolidation: an update. Ann. N.Y. Acad. Sci. 2010, 1191:27-41.
23. Nader K., Schafe G.E., LeDoux J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000, 406:722-726.
24. Guide for the Care and Use of laboratory Animals 2011, National Research Council, National Academic Press, Washington, USA. eighth ed.
25. Ohno H., Cole S.L., Yasvoinia M., Zhao J., Citron M., Berry R., Disterhoft J.F., Vassar R. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol. Dis. 2007, 26:134-145.
26. Ohno M. Failures to reconsolidate memory in a mouse model of Alzheimer's disease. Neurobiol. Learn. Mem. 2009, 92:455-459.
27. Perl D.P. Neuropathology of Alzheimer's disease. Mount Sinai J. Med. 2010, 77:32-42.
28. Rockenstein E., Torrance M., Adame A., Mante M., Bar-on P., Rose J.B., Crews L., Masliah E. Neuroprotective effects of regulators of the glycogen synthase kinase-3β signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. J. Neurosci. 2007, 27:1981-1991.
29. Selkoe D.J. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav. Brain Res. 2008, 192:106-113.
30. Shankar G.M., Li S., Mehta T.H., Garcia-Muñoz A., Shepardson N.E., Smith I. Amyloid β-protein dimers isolated directly from Alzheimer brains impair synaptic plasticity and memory. Nat. Med. 2008, 14:837-842.
31. Shen C.L., Murphy R.M. Solvent effects of self assembly of β-amyloid peptide. Biophys. J. 1995, 69:640-645. 1.
32. Son H., Yu I.T., Hwang S.J., Kim J.S., Lee S.H., Lee Y.S. Lithium enhances long-term potentiation independently of hippocampal neurogenesis in the rat dentate gyrus. J. Neurochem. 2003, 85:872-881.
33. Stephan A., Phillips A.G. A case for a non-transgenic animal model of Alzheimer's disease. Gen. Brain Behav. 2005, 4:157-172.
34. Texidó L., Martín-Satué M., Alberdi E., Solsona C., Matute Amyloid C. β-Peptide oligomers directly activate NMDA receptors. Cell Calcium 2011, 49:184-190.
35. Tozaki H., Matsumoto A., Kanno T., Nagai K., Nagata T., Yamamoto S. The inhibitory and facilitatory actions of amyloid-β peptides on nicotinic ACh receptors and AMPA receptors. Biochem. Biophys. Res. Commun. 2002, 294:42-45.
36. Tronson N.C., Taylor J.R. Molecular mechanisms of memory reconsolidation. Nat. Rev. Neurosci. 2007, 8:262-275.
37. Tsaltas E., Kontis D., Boulougouris V., Papadimitriou G.N. Lithium and cognitive enhancement: leave it or take it. Psychopharmacol 2009, 202:457-476.
38. Tsaltas E., Kontis D., Boulougouris V., Papakosta V.M., Giannou H., Poulopoulou C. Enhancing effects of chronic lithium on memory in the rat. Behav. Brain Res. 2007, 177:51-60.
39. Wang D., Yuen E.Y., Zhou Y., Yan Z., Xiang Y.K. Amyloid beta peptide-(1-42) induces internalization and degradation of beta-2 adrenergic receptors in prefrontal cortical neurons. J. Biol. Chem. 2011, 286:31852-31863.
40. Wu P., Xue Y.X., Ding Z., Xue L.F., Xu C., Lu L. Glycogen synthase kinase 3β in the basolateral amygdala is critical for the reconsolidation of cocaine reward memory. J. Neurochem. 2011, 118:113-125.